These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32861482)

  • 1. Successful Treatment of Early Post-Transplant Bloodstream and Pulmonary Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With a Combination of Ceftazidime-Avibactam and Carbapenem: A Case Report.
    Wang Z; Ma K; Chen Z; Guo Z; Zhao G; Guo H; Zhu L; Chen G
    Transplant Proc; 2020 Nov; 52(9):2742-2746. PubMed ID: 32861482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem.
    Wang ZQ; Guo ZL; Feng H; Fu C; Zhao GY; Ma K; Zhu L; Chen G
    Curr Med Sci; 2021 Aug; 41(4):770-776. PubMed ID: 34403102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of ventriculitis caused by
    Gofman N; To K; Whitman M; Garcia-Morales E
    Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for and clinical outcomes of ceftazidime-avibactam-resistant carbapenem-resistant Klebsiella pneumoniae nosocomial infections: a single-center retrospective study.
    Liu X; Chu Y; Yue H; Huang X; Zhou G
    Infection; 2022 Oct; 50(5):1147-1154. PubMed ID: 35182356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime-avibactam-based combination therapy for hospital-acquired central nervous system infections caused by carbapenem-resistant Klebsiella pneumoniae.
    Zhao X; Li S; Zhang Y; Wang J; Wang C; Qin X; Hu F; Wang M
    Int J Antimicrob Agents; 2023 May; 61(5):106777. PubMed ID: 36905946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime-avibactam.
    Cani E; Moussavi F; Ocheretyaner E; Sharma R; Brown C; Eilertson B
    Transpl Infect Dis; 2018 Apr; 20(2):e12837. PubMed ID: 29359842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant
    Han X; Shi Q; Mao Y; Quan J; Zhang P; Lan P; Jiang Y; Zhao D; Wu X; Hua X; Yu Y
    Front Cell Infect Microbiol; 2021; 11():757470. PubMed ID: 34760723
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
    Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
    J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of carbapenem-resistant
    Wang Y; Lei H; Zhang Y; Yang Q; Wang Y; Wang J; Xu C; Yu J; Zhou L; Kang X; Cui L
    Antimicrob Resist Infect Control; 2018; 7():66. PubMed ID: 29942492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R; Petraitis V; Kavaliauskas P; Maung BBW; Khan F; Naing E; Aung T; Zigmantaite V; Grigaleviciute R; Kucinskas A; Stakauskas R; Georgiades BN; Mazur CA; Hayden JA; Satlin MJ; Walsh TJ
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015048
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    Holyk A; Belden V; Lee JJ; Musick W; Keul R; Britz GW; Lin J
    J Antimicrob Chemother; 2018 Jan; 73(1):254-256. PubMed ID: 29040635
    [No Abstract]   [Full Text] [Related]  

  • 13. A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Luterbach CL; Qiu H; Hanafin PO; Sharma R; Piscitelli J; Lin FC; Ilomaki J; Cober E; Salata RA; Kalayjian RC; Watkins RR; Doi Y; Kaye KS; Nation RL; Bonomo RA; Landersdorfer CB; van Duin D; Rao GG;
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0059122. PubMed ID: 36125299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of preservative fluid associated possible donor-derived carbapenem-resistant Klebsiella Pneumoniae infection on kidney transplantation recipients.
    Zhang F; Zhong J; Ding H; Liao G
    BMC Nephrol; 2022 Mar; 23(1):101. PubMed ID: 35287599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
    Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
    Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia.
    Shields RK; Nguyen MH; Chen L; Press EG; Potoski BA; Marini RV; Doi Y; Kreiswirth BN; Clancy CJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam.
    Huang YT; Kuo YW; Teng LJ; Liao CH; Hsueh PR
    J Glob Antimicrob Resist; 2021 Sep; 26():301-307. PubMed ID: 34303027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.
    Varotti G; Dodi F; Terulla A; Santori G; Mariottini G; Bertocchi M; Marchese A; Fontana I
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28796391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allograft hemorrhage as a manifestation of carbapenem-resistant Klebsiella pneumonia infection in kidney transplant recipients: Case series.
    Wang Z; Qian Y; Bai H; Yang J; Li X
    Medicine (Baltimore); 2020 Mar; 99(13):e18982. PubMed ID: 32221060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.